Uta Höpken
6Patents
1h-index
10Co-inventors
44Inventor score
Filing activity: Nov 1, 2013 → May 17, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10189906B2 | Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases | Chemistry; Metallurgy | 6 | Active |
| US12351640B2 | Chimeric antigen receptor and CAR-T cells that bind BCMA | Chemistry; Metallurgy | 0 | Active |
| US10745486B2 | Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US11643468B2 | Chimeric antigen receptors and CAR-T cells that bind CXCR5 and methods of use thereof to treat medical disorders | Chemistry; Metallurgy | 0 | Active |
| US12048718B2 | Chimeric antigen receptor and CAR-T cells that bind BCMA | Chemistry; Metallurgy | 0 | Active |
| US11667722B2 | Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.